Thomas Ramdahl appointed Managing Director of Algeta ASA
March 14, 2014 06:09 ET
|
Algeta ASA
OSLO, Norway, March 14, 2014 (GLOBE NEWSWIRE) -- Dr. Ramdahl succeeds Algeta's former CEO Andrew Kay.
Thomas Ramdahl has been with Algeta in various leadership roles since 2001, including serving...
Algeta ASA: Bayer's voluntary cash offer to acquire the entire issued share capital of Algeta is successful
February 26, 2014 04:31 ET
|
Algeta ASA
OSLO, Norway, Feb. 26, 2014 (GLOBE NEWSWIRE) -- Algeta ASA ("Algeta"; OSE: ALGETA) today reported that Bayer has announced that 97.28% of all Algeta shares have been tendered to Aviator Acquisition...
Algeta ASA : Algeta results for the fourth quarter and full year 2013
February 05, 2014 01:19 ET
|
Algeta ASA
OSLO, Norway, Feb. 5, 2014 (GLOBE NEWSWIRE) -- Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, announces its financial results for the fourth...
Algeta ASA: Algeta announces change to Financial Calendar
January 20, 2014 02:48 ET
|
Algeta ASA
OSLO, Norway, Jan. 20, 2014 (GLOBE NEWSWIRE) -- Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, announces an update to its financial...
Algeta ASA: Bayer commences voluntary cash offer to acquire the entire issued share capital of Algeta
January 20, 2014 02:38 ET
|
Algeta ASA
OSLO, Norway, Jan. 20, 2014 (GLOBE NEWSWIRE) -- Algeta ASA ("Algeta"; OSE: ALGETA) today announced that Aviator Acquisition AS, a wholly-owned subsidiary of Bayer Nordic SE, has commenced the...
Algeta ASA: German competition authority clearance obtained for voluntary cash offer from Bayer to acquire the entire issued share capital of Algeta
January 06, 2014 01:02 ET
|
Algeta ASA
OSLO, Norway, Jan. 6, 2014 (GLOBE NEWSWIRE) -- Algeta ASA ("Algeta"; OSE: ALGETA) today announced that regulatory approval by German competition authorities, specifically the Federal Cartel Office...
The Board of Directors of Algeta ASA unanimously recommends voluntary cash offer from Bayer to acquire the entire issued share capital of Algeta
December 19, 2013 02:07 ET
|
Algeta ASA
Intended for US media only
Offer at NOK 362 per Algeta share, in cash, valuing the total share capital of Algeta at approximately NOK 17.6 billion (USD 2.9 billion) on a fully diluted...
Algeta ASA: The Board of Directors of Algeta ASA confirms that it is in receipt of a preliminary acquisition proposal from Bayer AG
November 26, 2013 01:48 ET
|
Algeta ASA
In response to recent media commentary, the Board of Directors of Algeta ASA confirms that it is in receipt of a preliminary acquisition proposal from Bayer AG.
The commentary in the media...
Algeta to host Capital Markets Days
November 18, 2013 01:14 ET
|
Algeta ASA
OSLO, Norway, Nov. 18, 2013 (GLOBE NEWSWIRE) --
Intended for US media only
Algeta ASA (OSE: ALGETA), a company focused on
the development of novel targeted cancer therapeutics, will host Capital...
Algeta ASA : Xofigo(R) (radium Ra 223 dichloride) injection granted Marketing Authorization in the European Union
November 15, 2013 05:21 ET
|
Algeta ASA
OSLO, Norway, Nov. 15, 2013 (GLOBE NEWSWIRE) --
Intended for US media only
Oslo, Norway, 15 November 2013 - Algeta ASA (OSE: ALGETA) announces today that
Bayer has received marketing ...